ASN Kidney Week 2024 was an exciting time for Hiddo Heerspink, PhD. He won the Donald W. Seldin Young Investigator Award and gave the Seldin address in addition to co-authoring several Kidney Week abstracts. Dr. Heerspink was an author of a late-breaking oral presentation on SC0062, a new selective endothelin receptor type A antagonist in IgAN, and a high-impact abstract on effects of semaglutide on kidney parameters with obesity and nondiabetic CKD. He spoke with Joel Topf, MD, about the findings and his award win.